Postmenopausal Osteoporosis Awareness & Management in Women-An Indian Perspective

Authors: Singh N, Patel A, Patil N*, Sharma A and Shrivastava R

DOI: 10.23880/whsj-16000155

Volume 5, Issue 1

Abstract

Postmenopausal osteoporosis affects millions of women each year jeopardising their healthcare and quality of life. Initial treatment is based on many factors including T-score, fracture risk assessment tool score, and risk factors for fractures. The most recent additions to treatment are aimed at those who are considered to be at higher fracture risk. The newest FDA-approved medications, abaloparatide and Romosozumab that work to increase bone formation in 18 and 12 months, respectively. Due to lack of awareness in Indian women and with the increase in life expectancy as proved by recent studies, it’s important to find out new medications and better lifestyle options for better management of Postmenopausal osteoporosis to help avoid fragility fractures and improve the quality of life of the Indian women.

Keywords: Menopause; Osteoporosis; Postmenopausal; Antiresorptive

View PDF